June 4, 2025
— 5 min read
June 4, 2025
— 5 min read
June 4, 2025
— 5 min read
Whole-Body MRI: A Powerful Tool for Early Disease Detection
Whole-Body MRI: A Powerful Tool for Early Disease Detection
Whole-Body MRI: A Powerful Tool for Early Disease Detection
Whole-body MRI is a radiation-free scan that looks for hidden cancers, aneurysms, and other major diseases before symptoms appear. To use it effectively, it’s important to understand both its strengths and limitations so findings can lead to meaningful action and better long-term health.
Whole-body MRI is a radiation-free scan that looks for hidden cancers, aneurysms, and other major diseases before symptoms appear. To use it effectively, it’s important to understand both its strengths and limitations so findings can lead to meaningful action and better long-term health.
Whole-body MRI is a radiation-free scan that looks for hidden cancers, aneurysms, and other major diseases before symptoms appear. To use it effectively, it’s important to understand both its strengths and limitations so findings can lead to meaningful action and better long-term health.

Michael Doney
Executive Medical Director

Michael Doney
Executive Medical Director

Michael Doney
Executive Medical Director



Why Whole-Body MRI Is Making Headlines
Whole-body MRI, often called full-body MRI, has captured public attention. Celebrities swear by it, preventive health startups promote it on social media, and health-conscious patients increasingly ask, “Should I get one?” The promise is compelling: a single, non-invasive scan that looks across your entire body for hidden diseases, often before symptoms appear. But does it truly deliver on its promise of early detection?
This blog is part one of a two-part series. Part one focuses on the strengths and limitations of whole-body MRI. In part two, we explore how Biograph has built one of the most advanced MRI programs available today, combining cutting-edge imaging, expert interpretation, and a personalized prevention plan designed to deliver meaningful health outcomes.
The Problem Whole-Body MRI is Trying to Solve
Most chronic diseases develop silently, often for years. For example:
More than 50% of pancreatic cancers are diagnosed after metastasis.
80% of people with prediabetes don’t know they have it.
Alzheimer’s disease-related brain changes can begin 20 years before symptoms show.
These delays cost lives and shorten healthspan.
While today’s healthcare system excels at treating late-stage disease, it struggles with early detection. Conventional screenings focus on narrow, organ-specific tests or age-based guidelines, leaving many risks undetected until they become serious.
Several companies now offer standalone full-body MRI scans to help fill this gap. Prenuvo, SimoneOne, and Ezra (recently acquired by Function Health) have become prominent in this growing space, offering direct-to-consumer whole-body MRI services that emphasize early disease detection, convenience, and proactive care.
But like any powerful tool, it is important to understand both its strengths and its limitations.
What Whole-Body MRI Can Detect
Whole-body MRIs have the potential to provide a high-resolution, radiation-free look across nearly all major organ systems. Research shows it is particularly strong at detecting:

Early-stage cancers
Malignancies in the kidney, liver, pancreas, prostate, uterus, and lymph nodes, often before symptoms appear. Studies in asymptomatic, average-risk adults show ~1.5 percent overall rate of biopsy-confirmed cancer.

Elevated visceral and liver fat
Early markers of metabolic and cardiovascular risk, affecting more than 24 percent of U.S. adults, often without symptoms.

Aortic and cerebral aneurysms
Roughly 1 to 3 percent of adults may harbor asymptomatic cerebral aneurysms that are at risk of rupture.

Silent brain damage
Small areas of injury from microvascular disease, including lacunar infarcts, which may double the risk of dementia and stroke and are present in up to 20 percent of healthy seniors.

Cysts and masses
Findings that may not be immediately dangerous but require careful interpretation and follow-up to avoid over- or under-treatment.
This is not a typical checkup. It is a detailed scan that offers clues into your health trajectory, helping you understand risks you might otherwise never see and giving you the chance to act early. Yet even a powerful tool like MRI has important blind spots, and knowing what it misses is just as critical as knowing what it sees.
What Whole-Body MRI Misses and Why That Matters
Whole-body MRI can detect many silent conditions, but it is not a universal screening tool for all cancers. Relying on it alone can create blind spots, especially for cancers that are better detected by other methods.

Colorectal cancer
MRI does not reliably detect polyps or small lesions in the colon. Colonoscopy remains the gold standard for early detection.

Breast cancer
Noncontrast whole-body MRI cannot reliably identify all breast cancers. Dedicated breast cancer surveillance with mammography remains essential.

Lung cancer
Low-dose chest CT scan is currently the most effective screening method for lung cancer.

Cervical cancer
Pap smears and HPV testing are the most effective tools for early detection.

Skin cancer
Whole-body MRI does not evaluate the skin surface. Visual skin exams remain critical for identifying melanoma and other skin cancers.
This is why high-quality prevention programs do not rely on MRI alone. They combine the strengths of multiple screening tools to catch risks early and accurately.
The Challenge of Incidental Findings
Whole-body MRI is highly sensitive, which makes it a powerful tool for early detection but also means it sometimes picks up findings that are ultimately harmless. These incidental findings can occasionally lead to extra scans, biopsies, or follow-ups that turn out unnecessary.
This creates two main challenges:
False positives: Findings such as liver and kidney cysts that are likely to never pose a real health threat but can lead to overtreatment if not carefully interpreted.
False negatives: Important findings that are unrecognized or inappropriately classified as benign.
Striking the right balance between false positives and false negatives is critical. A well-designed MRI program must be both sensitive and specific to detect true risks without causing unnecessary alarm. Not all MRI programs are built to navigate this balance with precision.
Biograph’s whole-body MRI program is designed to minimize unnecessary interventions without missing the issues that matter most. Every scan is reviewed by multiple fellowship-trained radiologists. A neuroradiologist interprets the brain and spine, a body radiologist evaluates the rest of the body, and a third radiologist conducts a separate quality control review. These expert interpretations are combined with advanced imaging protocols, family and personal history, genetic testing, lab and other test results. Our physician team then reviews each case to ensure findings are clearly explained and linked to a personalized action plan.
We go deeper into this approach in part two of this blog series, where we explain how Biograph’s MRI program was built to overcome these challenges and deliver meaningful, personalized prevention.
The Bottom Line
Whole-body MRI is one of the most advanced tools available for early detection. It can uncover hidden cancers, vascular risks, metabolic dysfunction, and brain changes, often long before symptoms appear.
Yet no test is a blanket solution for every risk. Its true power comes only when paired with expert interpretation, clinical context, and a personalized action plan. A scan without follow-through is just data; what matters is turning those insights into meaningful, preventive care.
Experts agree that whole-body MRI is best used as part of a thoughtful, personalized prevention plan. When applied wisely, it has the potential to improve long-term health in ways that standard screenings alone cannot.
Want to see how Biograph’s MRI program is delivering the world’s most advanced early detection system?

Go Beyond the MRI Scan
Biograph delivers more than imaging — we turn findings into a personalized prevention strategy.

Written by Michael Doney
Executive Medical Director
Dr. Doney is Biograph’s Executive Medical Director, overseeing our entire clinical team. Prior to joining Biograph, he served as Director of Medical Affairs at Human Longevity and Group42 Healthcare, and spent 4 years at the US CDC as an Associate Division Director. He received his medical degree from the University of Cincinnati and completed his residency in emergency medicine at UC San Diego.
References
SEER. Cancer Stat Facts: Pancreas Cancer. National Cancer Institute. https://seer.cancer.gov/statfacts/html/pancreas.html
CDC. Prediabetes: Prevent Type 2. Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/prevention-type-2/prediabetes-prevent-type-2.html
Alzheimer’s Association. Brain Tour Part 2.
https://www.alz.org/alzheimers-dementia/what-is-alzheimers/brain-tour-part-2Pecoraro V, Clemente C, Luchetti M, et al. Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol. 2021;94(1128):20210034. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558201
American Liver Foundation. Facts About Liver Disease.
https://liverfoundation.org/about-your-liver/facts-about-liver-disease/fatty-liver-disease/Welch HG, Schwartz LM, Woloshin S. Overdiagnosed: making people sick in the pursuit of health. BMJ. 2011;342:d1585. https://pubmed.ncbi.nlm.nih.gov/21641282/
Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9(1):119–128. https://www.thelancet.com/journals/laneur/article/PIIS1474442207701709/abstract
Why Whole-Body MRI Is Making Headlines
Whole-body MRI, often called full-body MRI, has captured public attention. Celebrities swear by it, preventive health startups promote it on social media, and health-conscious patients increasingly ask, “Should I get one?” The promise is compelling: a single, non-invasive scan that looks across your entire body for hidden diseases, often before symptoms appear. But does it truly deliver on its promise of early detection?
This blog is part one of a two-part series. Part one focuses on the strengths and limitations of whole-body MRI. In part two, we explore how Biograph has built one of the most advanced MRI programs available today, combining cutting-edge imaging, expert interpretation, and a personalized prevention plan designed to deliver meaningful health outcomes.
The Problem Whole-Body MRI is Trying to Solve
Most chronic diseases develop silently, often for years. For example:
More than 50% of pancreatic cancers are diagnosed after metastasis.
80% of people with prediabetes don’t know they have it.
Alzheimer’s disease-related brain changes can begin 20 years before symptoms show.
These delays cost lives and shorten healthspan.
While today’s healthcare system excels at treating late-stage disease, it struggles with early detection. Conventional screenings focus on narrow, organ-specific tests or age-based guidelines, leaving many risks undetected until they become serious.
Several companies now offer standalone full-body MRI scans to help fill this gap. Prenuvo, SimoneOne, and Ezra (recently acquired by Function Health) have become prominent in this growing space, offering direct-to-consumer whole-body MRI services that emphasize early disease detection, convenience, and proactive care.
But like any powerful tool, it is important to understand both its strengths and its limitations.
What Whole-Body MRI Can Detect
Whole-body MRIs have the potential to provide a high-resolution, radiation-free look across nearly all major organ systems. Research shows it is particularly strong at detecting:

Early-stage cancers
Malignancies in the kidney, liver, pancreas, prostate, uterus, and lymph nodes, often before symptoms appear. Studies in asymptomatic, average-risk adults show ~1.5 percent overall rate of biopsy-confirmed cancer.

Elevated visceral and liver fat
Early markers of metabolic and cardiovascular risk, affecting more than 24 percent of U.S. adults, often without symptoms.

Aortic and cerebral aneurysms
Roughly 1 to 3 percent of adults may harbor asymptomatic cerebral aneurysms that are at risk of rupture.

Silent brain damage
Small areas of injury from microvascular disease, including lacunar infarcts, which may double the risk of dementia and stroke and are present in up to 20 percent of healthy seniors.

Cysts and masses
Findings that may not be immediately dangerous but require careful interpretation and follow-up to avoid over- or under-treatment.
This is not a typical checkup. It is a detailed scan that offers clues into your health trajectory, helping you understand risks you might otherwise never see and giving you the chance to act early. Yet even a powerful tool like MRI has important blind spots, and knowing what it misses is just as critical as knowing what it sees.
What Whole-Body MRI Misses and Why That Matters
Whole-body MRI can detect many silent conditions, but it is not a universal screening tool for all cancers. Relying on it alone can create blind spots, especially for cancers that are better detected by other methods.

Colorectal cancer
MRI does not reliably detect polyps or small lesions in the colon. Colonoscopy remains the gold standard for early detection.

Breast cancer
Noncontrast whole-body MRI cannot reliably identify all breast cancers. Dedicated breast cancer surveillance with mammography remains essential.

Lung cancer
Low-dose chest CT scan is currently the most effective screening method for lung cancer.

Cervical cancer
Pap smears and HPV testing are the most effective tools for early detection.

Skin cancer
Whole-body MRI does not evaluate the skin surface. Visual skin exams remain critical for identifying melanoma and other skin cancers.
This is why high-quality prevention programs do not rely on MRI alone. They combine the strengths of multiple screening tools to catch risks early and accurately.
The Challenge of Incidental Findings
Whole-body MRI is highly sensitive, which makes it a powerful tool for early detection but also means it sometimes picks up findings that are ultimately harmless. These incidental findings can occasionally lead to extra scans, biopsies, or follow-ups that turn out unnecessary.
This creates two main challenges:
False positives: Findings such as liver and kidney cysts that are likely to never pose a real health threat but can lead to overtreatment if not carefully interpreted.
False negatives: Important findings that are unrecognized or inappropriately classified as benign.
Striking the right balance between false positives and false negatives is critical. A well-designed MRI program must be both sensitive and specific to detect true risks without causing unnecessary alarm. Not all MRI programs are built to navigate this balance with precision.
Biograph’s whole-body MRI program is designed to minimize unnecessary interventions without missing the issues that matter most. Every scan is reviewed by multiple fellowship-trained radiologists. A neuroradiologist interprets the brain and spine, a body radiologist evaluates the rest of the body, and a third radiologist conducts a separate quality control review. These expert interpretations are combined with advanced imaging protocols, family and personal history, genetic testing, lab and other test results. Our physician team then reviews each case to ensure findings are clearly explained and linked to a personalized action plan.
We go deeper into this approach in part two of this blog series, where we explain how Biograph’s MRI program was built to overcome these challenges and deliver meaningful, personalized prevention.
The Bottom Line
Whole-body MRI is one of the most advanced tools available for early detection. It can uncover hidden cancers, vascular risks, metabolic dysfunction, and brain changes, often long before symptoms appear.
Yet no test is a blanket solution for every risk. Its true power comes only when paired with expert interpretation, clinical context, and a personalized action plan. A scan without follow-through is just data; what matters is turning those insights into meaningful, preventive care.
Experts agree that whole-body MRI is best used as part of a thoughtful, personalized prevention plan. When applied wisely, it has the potential to improve long-term health in ways that standard screenings alone cannot.
Want to see how Biograph’s MRI program is delivering the world’s most advanced early detection system?

Go Beyond the MRI Scan
Biograph delivers more than imaging — we turn findings into a personalized prevention strategy.

Written by Michael Doney
Executive Medical Director
Dr. Doney is Biograph’s Executive Medical Director, overseeing our entire clinical team. Prior to joining Biograph, he served as Director of Medical Affairs at Human Longevity and Group42 Healthcare, and spent 4 years at the US CDC as an Associate Division Director. He received his medical degree from the University of Cincinnati and completed his residency in emergency medicine at UC San Diego.
References
SEER. Cancer Stat Facts: Pancreas Cancer. National Cancer Institute. https://seer.cancer.gov/statfacts/html/pancreas.html
CDC. Prediabetes: Prevent Type 2. Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/prevention-type-2/prediabetes-prevent-type-2.html
Alzheimer’s Association. Brain Tour Part 2.
https://www.alz.org/alzheimers-dementia/what-is-alzheimers/brain-tour-part-2Pecoraro V, Clemente C, Luchetti M, et al. Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol. 2021;94(1128):20210034. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558201
American Liver Foundation. Facts About Liver Disease.
https://liverfoundation.org/about-your-liver/facts-about-liver-disease/fatty-liver-disease/Welch HG, Schwartz LM, Woloshin S. Overdiagnosed: making people sick in the pursuit of health. BMJ. 2011;342:d1585. https://pubmed.ncbi.nlm.nih.gov/21641282/
Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9(1):119–128. https://www.thelancet.com/journals/laneur/article/PIIS1474442207701709/abstract
Why Whole-Body MRI Is Making Headlines
Whole-body MRI, often called full-body MRI, has captured public attention. Celebrities swear by it, preventive health startups promote it on social media, and health-conscious patients increasingly ask, “Should I get one?” The promise is compelling: a single, non-invasive scan that looks across your entire body for hidden diseases, often before symptoms appear. But does it truly deliver on its promise of early detection?
This blog is part one of a two-part series. Part one focuses on the strengths and limitations of whole-body MRI. In part two, we explore how Biograph has built one of the most advanced MRI programs available today, combining cutting-edge imaging, expert interpretation, and a personalized prevention plan designed to deliver meaningful health outcomes.
The Problem Whole-Body MRI is Trying to Solve
Most chronic diseases develop silently, often for years. For example:
More than 50% of pancreatic cancers are diagnosed after metastasis.
80% of people with prediabetes don’t know they have it.
Alzheimer’s disease-related brain changes can begin 20 years before symptoms show.
These delays cost lives and shorten healthspan.
While today’s healthcare system excels at treating late-stage disease, it struggles with early detection. Conventional screenings focus on narrow, organ-specific tests or age-based guidelines, leaving many risks undetected until they become serious.
Several companies now offer standalone full-body MRI scans to help fill this gap. Prenuvo, SimoneOne, and Ezra (recently acquired by Function Health) have become prominent in this growing space, offering direct-to-consumer whole-body MRI services that emphasize early disease detection, convenience, and proactive care.
But like any powerful tool, it is important to understand both its strengths and its limitations.
What Whole-Body MRI Can Detect
Whole-body MRIs have the potential to provide a high-resolution, radiation-free look across nearly all major organ systems. Research shows it is particularly strong at detecting:

Early-stage cancers
Malignancies in the kidney, liver, pancreas, prostate, uterus, and lymph nodes, often before symptoms appear. Studies in asymptomatic, average-risk adults show ~1.5 percent overall rate of biopsy-confirmed cancer.

Elevated visceral and liver fat
Early markers of metabolic and cardiovascular risk, affecting more than 24 percent of U.S. adults, often without symptoms.

Aortic and cerebral aneurysms
Roughly 1 to 3 percent of adults may harbor asymptomatic cerebral aneurysms that are at risk of rupture.

Silent brain damage
Small areas of injury from microvascular disease, including lacunar infarcts, which may double the risk of dementia and stroke and are present in up to 20 percent of healthy seniors.

Cysts and masses
Findings that may not be immediately dangerous but require careful interpretation and follow-up to avoid over- or under-treatment.
This is not a typical checkup. It is a detailed scan that offers clues into your health trajectory, helping you understand risks you might otherwise never see and giving you the chance to act early. Yet even a powerful tool like MRI has important blind spots, and knowing what it misses is just as critical as knowing what it sees.
What Whole-Body MRI Misses and Why That Matters
Whole-body MRI can detect many silent conditions, but it is not a universal screening tool for all cancers. Relying on it alone can create blind spots, especially for cancers that are better detected by other methods.

Colorectal cancer
MRI does not reliably detect polyps or small lesions in the colon. Colonoscopy remains the gold standard for early detection.

Breast cancer
Noncontrast whole-body MRI cannot reliably identify all breast cancers. Dedicated breast cancer surveillance with mammography remains essential.

Lung cancer
Low-dose chest CT scan is currently the most effective screening method for lung cancer.

Cervical cancer
Pap smears and HPV testing are the most effective tools for early detection.

Skin cancer
Whole-body MRI does not evaluate the skin surface. Visual skin exams remain critical for identifying melanoma and other skin cancers.
This is why high-quality prevention programs do not rely on MRI alone. They combine the strengths of multiple screening tools to catch risks early and accurately.
The Challenge of Incidental Findings
Whole-body MRI is highly sensitive, which makes it a powerful tool for early detection but also means it sometimes picks up findings that are ultimately harmless. These incidental findings can occasionally lead to extra scans, biopsies, or follow-ups that turn out unnecessary.
This creates two main challenges:
False positives: Findings such as liver and kidney cysts that are likely to never pose a real health threat but can lead to overtreatment if not carefully interpreted.
False negatives: Important findings that are unrecognized or inappropriately classified as benign.
Striking the right balance between false positives and false negatives is critical. A well-designed MRI program must be both sensitive and specific to detect true risks without causing unnecessary alarm. Not all MRI programs are built to navigate this balance with precision.
Biograph’s whole-body MRI program is designed to minimize unnecessary interventions without missing the issues that matter most. Every scan is reviewed by multiple fellowship-trained radiologists. A neuroradiologist interprets the brain and spine, a body radiologist evaluates the rest of the body, and a third radiologist conducts a separate quality control review. These expert interpretations are combined with advanced imaging protocols, family and personal history, genetic testing, lab and other test results. Our physician team then reviews each case to ensure findings are clearly explained and linked to a personalized action plan.
We go deeper into this approach in part two of this blog series, where we explain how Biograph’s MRI program was built to overcome these challenges and deliver meaningful, personalized prevention.
The Bottom Line
Whole-body MRI is one of the most advanced tools available for early detection. It can uncover hidden cancers, vascular risks, metabolic dysfunction, and brain changes, often long before symptoms appear.
Yet no test is a blanket solution for every risk. Its true power comes only when paired with expert interpretation, clinical context, and a personalized action plan. A scan without follow-through is just data; what matters is turning those insights into meaningful, preventive care.
Experts agree that whole-body MRI is best used as part of a thoughtful, personalized prevention plan. When applied wisely, it has the potential to improve long-term health in ways that standard screenings alone cannot.
Want to see how Biograph’s MRI program is delivering the world’s most advanced early detection system?

Go Beyond the MRI Scan
Biograph delivers more than imaging — we turn findings into a personalized prevention strategy.

Written by Michael Doney
Executive Medical Director
Dr. Doney is Biograph’s Executive Medical Director, overseeing our entire clinical team. Prior to joining Biograph, he served as Director of Medical Affairs at Human Longevity and Group42 Healthcare, and spent 4 years at the US CDC as an Associate Division Director. He received his medical degree from the University of Cincinnati and completed his residency in emergency medicine at UC San Diego.
References
SEER. Cancer Stat Facts: Pancreas Cancer. National Cancer Institute. https://seer.cancer.gov/statfacts/html/pancreas.html
CDC. Prediabetes: Prevent Type 2. Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/prevention-type-2/prediabetes-prevent-type-2.html
Alzheimer’s Association. Brain Tour Part 2.
https://www.alz.org/alzheimers-dementia/what-is-alzheimers/brain-tour-part-2Pecoraro V, Clemente C, Luchetti M, et al. Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol. 2021;94(1128):20210034. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558201
American Liver Foundation. Facts About Liver Disease.
https://liverfoundation.org/about-your-liver/facts-about-liver-disease/fatty-liver-disease/Welch HG, Schwartz LM, Woloshin S. Overdiagnosed: making people sick in the pursuit of health. BMJ. 2011;342:d1585. https://pubmed.ncbi.nlm.nih.gov/21641282/
Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9(1):119–128. https://www.thelancet.com/journals/laneur/article/PIIS1474442207701709/abstract
Up next
Memberships that meet your individual needs
Compare Memberships
->
MEMBERSHIPS
LOCATIONS
Compare Memberships
MEMBERSHIPS
LOCATIONS
Compare Memberships